Synthomer Plc · LSE:SYNT

Synthomer — H1 2026 Earnings Presentation

26 slides from Synthomer's earnings presentation, Aug 4, 2026

  1. Slide 1: Strong H1 trading supported by strategic progress

    Strong H1 trading supported by strategic progress Synthomer plc | 2026 interim results Tuesday 4 August 2026 Synthomer plc 2026 interim results 1

  2. Slide 2: Important notice

    Important notice This presentation is being provided to you in good faith and solely contained therein have been obtained from sources believed to profit forecast or estimate for any period. Recipients of these for your information purposes, speaking as of the date hereof, be reliable, but that ther

  3. Slide 3: Agenda

    AGENDA 01 Overview – Michael Willome 02 Financial review – Iain Torrens 03 Strategic progress – Michael Willome 04 Outlook and summary – Michael Willome 05 Q&A Synthomer plc 2026 interim results 3

  4. Slide 4: Strong H1 trading supported by strategic progress

    Strong H1 trading supported by strategic progress H1 2026 results ahead of • +5% revenue (+2% vol, +3% price), +13% EBITDA, +36% EBIT growth on Continuing Group basis expectations • 10.1% EBITDA margin (+80bps) • Revenue growth in all divisions: led by product initiatives – intumescent coatings for

  5. Slide 5: Agenda

    AGENDA 01 Overview – Michael Willome 02 Financial review – Iain Torrens 03 Strategic progress – Michael Willome 04 Outlook and summary – Michael Willome 05 Q&A Synthomer plc 2026 interim results 5

  6. Slide 6: H1 26 group financial summary

    H1 26 group financial summary Ahead of expectations mainly driven by strategy delivery, with all divisions contributing • Continuing revenue +5.1% in CC 1 to £954m Underlying Continuing business2 – Group volume +2.3% led by strategic focus on new products and markets H1 % H1 % – Robust pass-through

  7. Slide 7: Coatings & Construction Solutions (CCS)

    Coatings & Construction Solutions (CCS) Shifting mix towards higher-margin products including through innovation • H1 26 divisional trading Underlying – Volume +2.5%, led by industrial coatings and energy solutions H1 % H1 % £m H1 26 H1 25 change change CC1 – Revenue +5.8% in CC 1 reflecting volume,

  8. Slide 8: Adhesive Solutions (AS)

    Adhesive Solutions (AS) New sustainability-focused products and China growth, moderated by reliability setbacks • H1 26 divisional trading Underlying – Volume +0.9% despite subdued market demand and temporary H1 % H1 % reliability issues in certain sites, with Q2 base chemical demand £m H1 26 H1 25

  9. Slide 9: Health & Protection and Performance Materials (HPPM)

    Health & Protection and Performance Materials (HPPM) Continued focus on long-term delivery, temporarily enhanced by higher H&P volumes in Q2 • H1 26 continuing divisional trading Underlying Continuing business2 – Revenue +7.2% in CC 1, reflecting +2.8% volume, mix and pass- H1 % H1 % through of high

  10. Slide 10: Balance sheet and liquidity

    Balance sheet and liquidity Focused on derisking and deleveraging the balance sheet • Core debt facilities Net debt2 (£m) – RCF and UKEF facilities refinanced in April – now mature February 2029 Dec Jun Dec Jun – Security and guarantee package provided by certain group companies Maturity 2024 2025 2

  11. Slide 11: Cash flow

    Cash flow FY 26 cash flow outlook increased; leverage of 4.0-4.35x expected by year end Free cash flow and net debt • Self-help/cost savings continue to support EBITDA £m H1 26 H1 25 FY 25 – Underlying self help and strategy progress set to continue into H2 Opening net debt (575.0) (597.0) (597.0) T

  12. Slide 12: Agenda

    AGENDA 01 Stronger foundations – Michael Willome 02 Financial review – Iain Torrens 03 Strategic progress – Michael Willome 04 Outlook and summary – Michael Willome 05 Q&A Synthomer plc 2026 interim results 12

  13. Slide 13: Synthomer's focus, strengthen, grow strategy

    Synthomer’s focus, strengthen, grow strategy Becoming a more focused, more resilient, higher quality business Synthomer is a speciality solutions platform for Coatings & Construction, Adhesives and Health & Protection market segments 01 02 03 04 05 Organic growth in Rigorous and Operational and Diff

  14. Slide 14: Strategic direction

    Strategic direction Increasing our specialisation, global position and efficiency Pre-new strategy Synthomer H1 26 Future Synthomer Portfolio Increasing % revenue base Speciality Base Speciality Base Speciality Base speciality vs. speciality weighting ~50% ~50% ~55% ~45% ~70% ~30% Geography More bal

  15. Slide 15: Coatings & Construction Solutions

    Coatings & Construction Solutions Delivering as a true speciality platform Our strategic opportunity • Increasing range of profitable growth opportunities – Strengthening presence in high growth sub-segments – e.g. intumescent coatings (vol doubled Leading positions with solutions to enhance energy

  16. Slide 16: Adhesive Solutions

    Adhesive Solutions Having successfully turned around the operating performance, growth increasingly in focus Our strategic opportunity • Growth and new business generation – Increasingly leveraging global production network and multi -year relationships with blue-chip Leading positions in EMEA and t

  17. Slide 17: Health & Protection and Performance Materials

    Health & Protection and Performance Materials Strong H&P performance in Q2 highlights operating leverage of base chemicals products Our strategic opportunity • H&P performance strongly correlated with competitor dynamics in period – Underlying glove demand growth remains robust; pricing and margins

  18. Slide 18: Agenda

    AGENDA 01 Overview – Michael Willome 02 Financial review – Iain Torrens 03 Strategic progress – Michael Willome 04 Outlook and summary – Michael Willome 05 Q&A Synthomer plc 2026 interim results 18

  19. Slide 19: Current trading and outlook

    Current trading and outlook Full year 2026 outlook upgraded to slightly ahead of market expectations 1 • H1 2026: Good progress delivered mainly from sustainable, strategic growth and further self help – Led by new products and markets, enhancing innovation and market positioning, and cost actions –

  20. Slide 20: Summary

    Summary Further strategic progress delivering sustainable trading momentum Substantial earnings growth ambitions in medium term: • Continuing to deliver strategic transformation towards speciality – Further self-help actions now more than ever it is the right strategy + • Encouraging new product and

  21. Slide 21: Agenda

    AGENDA 01 Overview – Michael Willome 02 Financial review – Iain Torrens 03 Strategic progress – Michael Willome 04 Outlook and summary – Michael Willome 05 Q&A Synthomer plc 2026 interim results 21

  22. Slide 22: Appendices

    APPENDICES 01 Special items 02 Foreign exchange and pensions 03 Operational excellence 04 Driving innovation and sustainability Synthomer plc 2026 interim results 22

  23. Slide 23: H1 26 special items

    Appendix 1 H1 26 special items Continuing operations £m H1 26 H1 25 FY 25 • Amortisation of acquired intangibles reflects the amortisation on the customer lists, patents, trademarks and trade secrets that arose on historic acquisitions Amortisation of acquired intangibles (22.0) (22.3) (44.4) • Rest

  24. Slide 24: Foreign exchange and pensions

    Appendix 2 Foreign exchange and pensions FX translation exposure – EBITDA impact Pensions H1 26 translation • Net retirement obligation decreased by £3.5m to £36.1m at 30 June 2026, Currency Movement sensitivity primarily driven by £2.3m of cash contributions and actuarial gains of £7.7m partially o

  25. Slide 25: Operational excellence

    Appendix 3 Operational excellence Continuous improvement in how we run our business is a key pillar of the strategy SHE excellence Procurement Synthomer Excellence (SynEx) SynEx community • Centrally-managed ‘business excellence’ function launched in Oct 2022 • 3 Master black belts / 12 black belts

  26. Slide 26: Driving innovation and sustainability

    Appendix 4 Driving innovation and sustainability Further progress in key initiatives underpinning future growth Our sustainability approach is commercially-led and aligned to innovation agenda… • ISCC+ certified sites increased by 3 to 11 – mass balance-based product offerings for customers using bi

Synthomer — H1 2026 Earnings Presentation on 6ix